NCT01968811

Brief Summary

The investigation is a Post Marketing Follow-Up Study for the Avance Foam Abdominal Dressing Kit conducted as part of Mölnlycke Health Care's quality system. The primary objective is to evaluate the dressing kit as part of a negative pressure system. The secondary objectives are to collect and evaluate safety data, performance data and information on technical complications.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 14, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 24, 2013

Completed
8 days until next milestone

Study Start

First participant enrolled

November 1, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

May 11, 2016

Completed
Last Updated

May 11, 2016

Status Verified

May 1, 2014

Enrollment Period

4 months

First QC Date

October 14, 2013

Results QC Date

June 10, 2015

Last Update Submit

April 6, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • To Evaluate the Performance of the Dressing Kit as Part of a Negative Pressure System in Post Market Clinical Follow-up Settings

    Outcome of each subject was evaluated and presented individually. Questionnaires answered by surgeon at application and removal of the kit; Baseline Overall ease of application of the kit: No. of surgeons rated as; Very easy= 4/Easy=3/Somewhat easy=2/Not easy Overall satisfaction with the kit:No. of surgeons rated as Very satisfied=3/ Satisfied=5/ Unsatisfied=2/ Very unsatisfied=0 Questionnaires were answered by surgeon at application and removal of the kit; Visit 2 Overall ease of application of the kit:No.of surgeons rated as Very easy= 2/Easy=5/Somewhat easy=0/Not easy=1 Overall satisfaction with the kit: No.of surgeons rated as Very satisfied=1/ Satisfied=3/ Unsatisfied=4/ Very unsatisfied=0 Visit 3 Overall ease of application of the kit: No.of surgeons rated as Very easy= 0/Easy=6/Somewhat easy=0/Not easy=0 Overall satisfaction. No of surgeons rated as Very satisfied=0, satisfied=4, unsatisfied=2, very unsatisfied=0

    From 1 to 3 visit, depending on each subject/wound, up to 4 days.

Secondary Outcomes (1)

  • - Fascial/Skin Closure of the Open Abdomen

    End of treatment, up to 4 days.

Study Arms (1)

Avance foam, abdominal dressing kit

EXPERIMENTAL
Device: Avance Foam dressing kit

Interventions

Avance foam, abdominal dressing kit

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Provision of written informed consent from subject or family member
  • Subjects with open abdomen suitable for temporary closure with NPWT therapy
  • Subjects where the viscera and/or abdominal organs need to be protected by an abdominal organ contact layer (OCL)
  • Subject which (at the time of the baseline visit) are planned to be cared for between dressing changes at Intensive Care Unit
  • Male or female, 18 years and above

You may not qualify if:

  • Synthetic mesh inserted in the abdomen
  • Non-enteric fistulae or unexplored fistulas
  • Untreated osteomyelitis
  • Malignant wounds
  • Abdominal wall hernia
  • Subjects previously treated with an NPWT abdominal dressing
  • Known allergy or hypersensitivity to any of the components in the dressing
  • Pregnancy
  • Subjects not suitable for the investigation according to the investigator's judgement
  • Subjects included in other ongoing clinical investigation at present which could interfere with this investigation, as judged by the investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sahlgrenska University hospital

Gothenburg, 41345, Sweden

Location

Results Point of Contact

Title
Dr Marcus Langenskiöld
Organization
Sahlgrenska university Hospital

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 14, 2013

First Posted

October 24, 2013

Study Start

November 1, 2013

Primary Completion

March 1, 2014

Last Updated

May 11, 2016

Results First Posted

May 11, 2016

Record last verified: 2014-05

Locations